Fortress Biotech Reports First Quarter 2016 Financial Results and Recent Corporate Highlights May 10, 2016
Mustang Bio Announces Oral Presentation of Initial Clinical Data for MB-101 (IL13Ra2-specific CAR T cells) by City of Hope Investigators at the American Society of Gene and Cell Therapy 19th Annual Meeting May 05, 2016
Mustang Bio Announces Presentations of MB-101, a Novel IL13Ra2-specific CAR-T cells Product in Clinical Development, at the American Society of Gene and Cell Therapy 19th Annual Meeting Apr 18, 2016
Fortress Biotech Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 Mar 15, 2016
Fortress Biotech Reports Financial Results for the Third Quarter 2015 Ended September 30, 2015 Nov 09, 2015
Checkpoint Therapeutics Announces Appointment of James F. Oliviero, III, as President & Chief Executive Officer Oct 16, 2015
